Drug Profile
BAY 358535
Alternative Names: BAY 171998Latest Information Update: 04 Nov 1998
Price :
$50
*
At a glance
- Originator Celera Genomics Group
- Class Antiasthmatics
- Mechanism of Action Mast cell tryptase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 04 Nov 1998 Discontinued-Preclinical for Asthma (Inhalation)
- 20 Oct 1998 BAY 171998 is now called BAY 358535
- 31 Aug 1998 No-Development-Reported for Asthma (Inhalation)